Individual #00412602

ID_report ?
Reference PubMed: Lucas-Herald 2015
Remarks -
Gender M
Consanguinity -
Country -
Population white (Scottish / German)
Age at death -
VIP -
Data_av -
Treatment -
Panel size 1
Diseases ?
Owner name LOVD
Database submission license Creative Commons Attribution 4.0 InternationalCreative Commons License
Created by Anna Tracewska
Date created 2022-07-01 18:29:37 +02:00 (CEST)
Date last edited N/A


Phenotypes

unclassified / mixed (?)   Add phenotype for this disease

AscendingPhenotype ID     

Diagnosis/Initial     

Diagnosis/Definite     

Phenotype details     

Inheritance     

Age/Examination     

Age/Diagnosis     

Age/Onset     

Phenotype/Onset     

Protein     

Tumor/MSI     

Diagnosis/Criteria     

Owner     
0000304594 - ciliopathy with functional growth hormone deficiency and early growth retardation born at 42 weeks; hospitalised 3 days due to respiratory distress; slow to feed but did not require tube feeding or develop hypoglycemia, discharged on Day 5; no family history, three healthy siblings. 17m: short stature and obesity despite difficulty with weaning and feeding, body mass index high despite taking only 25 mL/kg/d of milk and minimal solids; midfacial hypoplasia, depressed nasal root, a single palmar crease, left-sided clinodactyly, and one small ( 0.5 cm) cafe-au-lait patch on the back; no evidence of microcephaly or genital abnormalities; 13.9 kg; length 75.4 cm (-2.3 SDs) and a body mass indexof24.4(+4.0 SDs); motor and personal skills delayed; language delay and poor attention noticed by the age of 3y but subsequently improved.; thyroid function tests age 1y normal; persisting, proportionate short stature at age 3.6 years, serum IGF-I was measured, ranging from 8-17 ng/mL (reference range, 40-100 ng/mL); arginine/ACTH stimulation test (0.5 g/kg arginine; 250 mcg synacthen): a peak GH level of 7.5 ng/mL and peak cortisol of 43.7 g/dL; LHRH stimulation test (100 mcg LHRH): basal levels of LH and FSH of 0.1 mIU/mL and 0.4 mIU/mL increasing to 2.7 mIU/mL and 1.9 mIU/mL, respectively, at 60 minutes; IGF-I generation test (25 mcg/kg GH once daily for 3 d): increase in serum IGF-I from 22 to 57 ng/mL; a trial of recombinant human growth hormone (rhGH) therapy (0.5 mg once daily[0.03 mcg/kg/d]) age 4 years, treatment continued as he displayed a good growth response with an increase in height velocity from 4.6 to 8.5 cm per year; 5y: magnetic resonance imaging (MRI) brain scan: anterior pituitary hypoplasia and an ectopic posterior pituitary gland, repeated 14.5y - no significant change, anterior pituitary continued to remain small despite normal entry and progress through puberty, repeat ACTH stimulation test at age 14.5 years: a peak cortisol of 26.6 g/dL at 60 minutes. 5y: bilateral knee pain and a waddling gait, and a skeletal survey showed marked metaphyseal dysplasia of the hips as well as some evidence at the knees and ankles without the presence of any other skeletal abnormalities such as cone shaped epiphyses; 9y: bilateral coxa vara and progressed to bilateral femoral osteotomy following a stress fracture of his right femoral neck; despite a normal ophthalmological examination and electroretinogram at 1y, by 9y he had increasing difficulty with vision, particularly at night; repeat electroretinogram demonstrated a retinopathy of his rods and cones; 11y: hypertension; ultrasound and dimercaptosuccinic acid radionuclide kidney scan: discrepancy in the size of his kidneys (right kidney, -1.2 SDs; left kidney, +0.5 SDs) and loss of cortical medullary differentiation but no scarring or difference in uptake; renal function deteriorated and at age 14y required hemodialysis, progressing to renal transplantation Familial, autosomal recessive - - 0m - - - - LOVD



Screenings


AscendingScreening ID     

Template     

Technique     

Tissue     

Remarks     

Genes screened     

Variants found     

Owner     
0000413871 DNA SEQ-NG;SEQ blood targeted or exome sequencing IFT172 2 LOVD



Variants

2 entries on 1 page. Showing entries 1 - 2.
Legend   How to query  

Chr     

Allele     

Effect     

Classification method     

Clinical classification     

AscendingDNA change (genomic) (hg19)     

DNA change (hg38)     

Published as     

ISCN     

DB-ID     

Variant remarks     

Reference     

ClinVar ID     

dbSNP ID     

Origin     

Segregation     

Frequency     

Re-site     

VIP     

Methylation     

Owner     

Gene     

IDbase Accession Number     

VariO/DNA     

VariO/Protein     

VariO/RNA     

Exon     

DNA change (cDNA)     

Haplotype     

RNA change     

Protein     

P-domain     

Exon_old     

Function/GVS     

Predict/AGVGD     

Predict/MutationTaster     

Predict/SIFT     

Predicted     

Type/DNA     

CpG     

Enzyme activity     

mRNA level     

Predict-BioInf     

Legacy protein change     

Protein level     
2 Parent #1 +?/. - likely pathogenic (recessive) g.27667370A>G g.27444503A>G IFT172 c.5179T>C, (p.Cys1727Arg) - IFT172_000140 heterozygous PubMed: Lucas-Herald 2015 - - Germline yes - - - - LOVD IFT172, KRTCAP3 - - - - - NM_015662.1:c.5179T>C, NM_173853.3:c.*323A>G - r.(?), r.(=) p.(Cys1727Arg), p.(=) - - - - - - - - - - - - - -
2 Parent #2 +?/. - likely pathogenic (recessive) g.27706806T>G g.27483939T>G IFT172 c.337-2A C, p.(?) - IFT172_000156 heterozygous PubMed: Lucas-Herald 2015 - - Germline yes - - - - LOVD IFT172 - - - - - NM_015662.1:c.337-2A>C - r.spl p.(?) - - - - - - - - - - - - - -
Legend   How to query  


Screenscraping/webscraping (downloading large amounts of data using scripts) is strictly prohibited.
Use our APIs to retrieve data.